ASNDVSSLS• 12 Months (Normalized)
ASND vs SLS (Ascendis Pharma A/S vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ASND Performance $263.52
+33.31%
Ascendis Pharma A/S
Normalized Baseline0.00%
SLS Performance $11.55
+511.11%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin SLS LEADS
-477.8%
SLS outperforming by 477.80%
ASNDSLS
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ASND SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | ASND Price | ASND Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $263.52 | +33.31% | $11.55 | +511.11% | -477.80% |
| Sep 10, 2026 | $261.23 | +32.15% | $13.49 | +613.76% | -581.61% |
| Sep 09, 2026 | $260.81 | +31.94% | $13.95 | +638.10% | -606.16% |
| Sep 08, 2026 | $270.09 | +36.64% | $13.96 | +638.62% | -601.98% |
| Sep 04, 2026 | $270.56 | +36.87% | $13.86 | +633.33% | -596.46% |
| Sep 03, 2026 | $271.12 | +37.16% | $13.70 | +624.87% | -587.71% |
| Sep 02, 2026 | $267.31 | +35.23% | $14.16 | +649.21% | -613.98% |
| Sep 01, 2026 | $260.25 | +31.66% | $13.22 | +599.47% | -567.81% |
| Aug 31, 2026 | $263.04 | +33.07% | $13.34 | +605.82% | -572.75% |
| Aug 28, 2026 | $247.91 | +25.42% | $13.21 | +598.94% | -573.52% |
| Aug 27, 2026 | $249.36 | +26.15% | $15.21 | +704.76% | -678.61% |
| Aug 26, 2026 | $250.25 | +26.60% | $13.73 | +626.46% | -599.86% |
| Aug 25, 2026 | $252.99 | +27.99% | $14.09 | +645.50% | -617.51% |
| Aug 24, 2026 | $251.95 | +27.46% | $14.33 | +658.20% | -630.74% |
| Aug 21, 2026 | $253.29 | +28.14% | $15.46 | +717.99% | -689.85% |
Page 1 of 17